title: Impact of long-term ethanol consumption on CYP1A2 activity.
abstract: Ethanol is a well-known inducer of CYP2E1; whether or not it is an inducer of other cytochromes has not been investigated systematically. The aim of our study was to evaluate the impact of ethanol consumption on the activity of CYP1A2, which has been shown to be influenced by drugs (inhibited or induced). We evaluated CYP1A2 activity by the ratio of the molar urinary concentrations of the three end products of paraxanthine demethylation of caffeine to the molar concentration of a paraxanthine 8-hydroxylation product. This urinary metabolite ratio has previously been shown to correlate with caffeine clearance. The caffeine metabolites were measured in urine collected during the 3 hours after oral administration of 200 mg caffeine. The caffeine test was performed in 12 smokers (> 25 cigarettes/day) and 12 nonsmokers, all of whom were alcoholic inpatients (daily intake > 100 mg absolute ethanol), within the first 3 days of their hospital stay and after 14 days of abstinence from ethanol. In alcoholic patients who were smokers the molar urinary concentration ratio was 3.14 +/- 0.97 before withdrawal and 4.01 +/- 0.92 after 14 days of abstinence from ethanol. In contrast, in alcoholic patients who were nonsmokers it was 2.62 +/- 0.95 and 2.18 +/- 0.96 before and after withdrawal, respectively. In volunteers who were smokers the molar urinary concentration ratio was 5.02 +/- 1.51, whereas in volunteers who were nonsmokers it was 3.22 +/- 1.46. Our results confirm the well-known induction of CYP1A2 activity by tobacco smoking and show that this induction is masked by long-term ethanol consumption.
authors.affiliation: Hôpital Lariboisiere, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Rizzo
authors.forename: E
authors.initials: E
authors.lastname: Hispard
authors.forename: S
authors.initials: S
authors.lastname: Dolbeault
authors.forename: S
authors.initials: S
authors.lastname: Dally
authors.forename: R
authors.initials: R
authors.lastname: Leverge
authors.forename: C
authors.initials: C
authors.lastname: Girre
mesh_terms: D000328:Adult; D000428:Alcohol Drinking / Q000378:metabolism*; D000437:Alcoholism / Q000201:enzymology*; D002110:Caffeine / Q000652:urine; D016022:Case-Control Studies; D019388:Cytochrome P-450 CYP1A2 / Q000187:drug effects*; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000652:urine; D012907:Smoking; D013997:Time Factors
chemical_list: D010726:Phosphodiesterase Inhibitors; D002110:Caffeine; D000431:Ethanol; D019388:Cytochrome P-450 CYP1A2